BSE filing, NSE: RUBYMILLS. Summary written from the filing by ALFA Finder's alert engine.
Ruby Mills Ltd: key numbers
- Share price
- ₹485.50
- Market cap
- ₹1,624 Cr
- Revenue (annual)
- ₹358.6 Cr
- Net profit (annual)
- ₹43.58 Cr
- P/E (TTM)
- 37.5×Sector 49.0×
- Promoter holding
- 74.90%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ruby Mills Ltd
All →Ruby Mills Other Announcement
The company has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations. This is a routine periodic filing.
Ruby Mills Annual General Meeting
Ruby Mills Ltd concluded its 110th Annual General Meeting on September 24, 2026. Shareholders approved all resolutions, including the final dividend and director remuneration.
Ruby Mills Dividend
The Ruby Mills Ltd has fixed September 17, 2026, as the record date for its final dividend. The company also announced e-voting and book closure dates.
Ruby Mills Annual Report
The Ruby Mills Limited has submitted its Annual Report for the Financial Year 2025-26, as required under SEBI listing regulations.
Ruby Mills Annual General Meeting
The Ruby Mills Limited has announced its 110th Annual General Meeting, scheduled to be held on September 24, 2026, via video conferencing.
Ruby Mills Merger & Restructuring Worth ₹124.1 Cr
The Ruby Mills Limited has sold commercial premises on the 33rd floor of 'The Ruby' to Torrent Pharmaceuticals Limited for Rs. 124.08 Crore.
- Value
- ₹124.1 Cr
Other other announcement announcements
All →ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.